|C - Cardiovascular System|
|C10 - Lipid Modifying Agents|
The DDDs are based on the treatment of hypercholesterolemia.
|C10A - Lipid Modifying Agents, plain|
Pantethine, which is also used in the treatment of hyperlipidemi, is classified as a vitamin in A11HA.
|C10AX - Other Lipid Modifying Agents|
This group comprises all cholesterol and triglyceride reducers, which cannot be classified in the preceding groups.
Icosapent ethyl is classified in C10AX06 - omega-3-triglycerides incl. other esters and acids.
Sulodexide is classified in B01AB.
The DDD for evolocumab is based on dosing every second week.